Life Sciences

spot_imgspot_img

Exai Bio Appoints Dave Daly as Chief Executive Officer

Exai to accelerate product development and partnering of its novel oncRNA- and generative AI-based liquid biopsy platform Exai Bio, a next-generation oncRNA- and generative AI-based...

Emmes Group partners with Miimansa AI to accelerate the use of generative AI in clinical research

Emmes Group, a leading global technology-focused contract research organization (CRO), announced a multi-year strategic partnership with Miimansa AI. A critical pillar of the partnership,...

COTA and Texas Oncology Collaborate to Advance AI-Enabled Precision Medicine

COTA, Inc., in collaboration with Texas Oncology’s Precision Health Informatics, LLC (PHI), announces an innovative collaboration aimed at revolutionizing precision medicine across Texas Oncology’s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img